Want to see IN:ANTHEM full AI Analyst Report?
Anthem Biosciences Limited (ANTHEM) Income Statement
Anthem Biosciences Limited Income Statement
Last quarter (Q2 2025), Anthem Biosciences Limited's total revenue was $5.50B. In Q2, Anthem Biosciences Limited's net income was $1.73B. See Anthem Biosciences Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 21.24B | $ 18.45B | $ 14.19B | $ 10.57B | $ 12.31B | |
| $ 8.95B | $ 11.01B | $ 8.20B | $ 7.18B | $ 8.22B | |
| $ 1.96B | $ 5.08B | $ 3.95B | $ 3.46B | $ 3.03B | |
| Depreciation and Amortization | $ 1.34B | $ 893.71M | $ 818.24M | $ 637.74M | $ 578.35M |
| $ 8.34B | $ 7.56B | $ 5.68B | $ 5.69B | $ 6.16B | |
| $ 7.00B | $ 5.92B | $ 4.25B | $ 3.72B | $ 5.19B | |
| $ 1.24B | $ 647.21M | $ 526.89M | $ 1.26B | $ 270.18M | |
| $ 8.24B | $ 6.57B | $ 4.77B | $ 4.97B | $ 5.46B | |
| $ 5.92B | $ 4.51B | $ 3.67B | $ 3.85B | $ 4.06B | |
| Per Share Metrics | |||||
| Basic EPS | $ 10.55 | $ 8.04 | $ 6.54 | $ 6.86 | $ 7.22 |
| Diluted EPS | $ 10.43 | $ 8.04 | $ 6.54 | $ 6.86 | $ 7.22 |
| Weighted Average Shares Outstanding | 560.94M | 561.61M | 561.61M | 561.61M | 561.61M |
| Weighted Average Shares Outstanding (Diluted) | 567.39M | 561.61M | 561.61M | 561.61M | 561.95M |
Currency in INR
